(Q69900263)

English

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer

scientific article published on 01 January 1985

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

multicenter clinical trial

1 reference

based on heuristic

inferred from title

metastatic breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

J M Bennett

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

P Byrne

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A Desai

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

C White

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

R DeConti

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

C Vogel

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

E Krementz

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J Doroshow

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

D Plotkin

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 January 1985

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

179-185

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3894279%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in metastatic breast cancer treated with combination chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy. A study by cancer and leukemia group B

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dihydroxyanthracenedione: A Promising New Drug in the Treatment of Metastatic Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of quality of life in patients receiving treatment for advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination chemotherapy with cyclophosphamide, mitoxantrone and 5-fluorouracil in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of disseminated breast cancer:Current status and prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/3894279

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69900263&oldid=2218772900"